You are in:Home/Publications/EF'FECT OF THE SELECTIVE COX2 INHIBITOR, ROFECOXIB VERSUS THE NON-SELECTTVE COX INHIBITOR& INDOMETHACIN ON RENAL HEMODYNAMICS AND TUBULAR EXCRETION.

Prof. Nasr N. Makar :: Publications:

Title:
EF'FECT OF THE SELECTIVE COX2 INHIBITOR, ROFECOXIB VERSUS THE NON-SELECTTVE COX INHIBITOR& INDOMETHACIN ON RENAL HEMODYNAMICS AND TUBULAR EXCRETION.
Authors: Abdel-Hamid M. Elhawary : Nasr N. Zaki and Mahmoud Elfouly
Year: 2002
Keywords: Not Available
Journal: J. Egypt. Soc. Pharmacol. Exp. Ther.
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper Not Available
Supplementary materials Not Available
Abstract:

Nonsteroidal anti-inflammatory drugs (NSAIDS) are among the most widely prescribed medications worldwide. The mechanism through which NSAIDs provide analgesia and suppress inflammation is the inhibition of the enzpe cyclo-oxygenase (Cox) with subsequent suppression of the prostanoids synthesis. The suppression of prostanoids synthesis can also produce gaskic and renal toxicity, as well as impair normal platelet function. Two distinct but related enzymes, cyclo-oxygenase-I (COX-l) and cyclo-oxygenase-2 (COX-2) mediate prostanoids synthesis and contribute to the inflammatory process. However, it is generally assumed that NSAIDs anti-inflammatory and analgesic activity is mediated via Cox-2 inhibition while inhibition of Cox-I is thought to be responsible for the gastric toxicity and bleeding complications. It is unclear whether NSAID-irduced renal toxicity is attributable to inhibition of Cox-I or Cox-2. The present study was designed to compare the effect of chronic administration of selective COX-2 inhibitor, rofecoxib, with that of the non selective COX inhibitor, indomethacin on renal hemodynamics and tubular excretion. Thus, changes in mean arterial pressure (MAp), renal blood flow (RBF),. glomerular filtration rate (GFR) urine volume and urinary Na+ and K+ excretion ratio, hematocrite value , serum Na* , l(*, urea and creatinine concenfiations were all de,tected after IM injection of rofecoxib (1.0 umoVkg), indomethacin (3 umoVkg) or the vehicle for three weeks. Results from the present study showed that three weeks treatnent with both indomethacin and rofecoxib induced a decrease in urine'volume and Na+ and K* excretion. Indomethacin but not rofecoxib reduced RBF and GFR. No significant change was observed in MAP, hematocrite value or serum Na+. Serum K+, urea and creatinine levels were all elevat"-d suggesting impairment in the renal functions. It seems likely that Cox-2 inhibition causes acute salt and water retention, whereas the decline in RBF and GFR is caused by the blockade of Cox-I. .COx-2 inhibitors should be used with caution since they are, like traditional NSAIDS, can induce renal function impairment.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus